Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. CVS
8. SWKS
9. SPY
10. XYZ

Go back to Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

March 27, 2025 4:05 PM EDT

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2024.

Recent Business Highlights

Soft Tissue Ablation

Announced positive preliminary results from its first-in-human feasibility study using Nanosecond Pulsed Field Ablation technology for the treatment of benign thyroid nodules at the North American Society for Interventional Thyroidology Annual Meeting. Advanced pilot... More